APOA1 and cholangiocarcinoma: ApoA-I may differentiate CCA from benign diseases of hepatobiliary and healthy individuals (AUC, 0.883) and other cancers including laryngopharyngeal, laryngeal, esophageal, prostate and lung cancer (AUC, 0.715).